Dr Biran Discusses Treatment Discontinuation In Myeloma | Latest News RSS feed

Dr Biran Discusses Treatment Discontinuation In Myeloma - Latest News


Celgene Corporation (CELG) CEO Discusses Q2 2013 Results - Earnings Call Transcript

Given the strength of the data package we now have, we’re moving forward with our plan to submit regulatory applications for REVLIMID for the treatment of newly diagnosed multiple myeloma in ... Last ... read more

Moves Slowly on Drug Warnings

Dr. Ruggiero, chief of oral and maxillofacial surgery at the ... recognition of suicide risk associated with pediatric antidepressant use, and Merck & Co.'s withdrawal of the painkiller Vioxx after a ... read more

Amgen's CEO Discusses Q3 2013 Results - Earnings Call Transcript

Oprozomib looks attractive as well as a potential oral proteasome inhibitor for maintenance therapy in multiple myeloma and of course we expect ... PLA for the product and the FDA has confirmed this w... read more

Looking for another news?


Drug summit convenes in Madras

MADRAS — “I don’t use the word gateway,” said Dr. Kevin Sabet to an attentive audience at ... Leriche declined to comment on Best Care’s withdrawal. Brian Hodges and Anna Unruh, substance-abuse counse... read more

WooCommerce

New series of lunchtime seminars launched with Wellcome Trust support

In the opening presentation to a capacity audience, Dr Jessica Reinisch, of Birkbeck College ... their skills in enhancing and shaping forest cover. Professor Fairhead discusses his findings. The Fren... read more

Lexicon Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

I am Wade Walke and with me today are Dr. Arthur Sands, Lexicon’s President and Chief Executive Officer, Dr. Brian Zambrowicz ... they were closely associated with initiation and discontinuation of tr... read more

U.S. surgeon general discusses opioid epidemic during forum in Sugar Grove

Randy Hultgren addresses a crowded conference room during a forum Wednesday on the opioid epidemic with Kane County Board Chairman Chris Lauzen (from left), U.S. Surgeon General Dr ... withdrawal, and ... read more

New cell therapy offers hope of a leukaemia cure

These patients had multiple myeloma, a type of blood cancer, and were followed for two months after their treatment. Dr Wanhong Zhao, the lead author from the Xi’an Jiaotong University in Xi’an, China ... read more

Robin Roberts: I will beat MDS

Her doctors tell her she's "younger and fitter than most people who confront this disease, and will be cured." Roberts starts pre-treatment today, and thankfully her sister is a bone marrow match, whi... read more

Did “Cosmos” Pick the Wrong Hero?

Science has advanced greatly as well. The updated Cosmos discusses free-floating planets between the stars, shows real images of Uranus and Neptune, and gives a precise age to the universe (that would ... read more

Life at 21 Weeks: Immature Lungs and a Handful of Fragile Skin and Pain

And there is the pain, treated with narcotics that can cause dependency and withdrawal symptoms ... "These babies survive, but they are extremely impaired," said Dr. Robert J. Boyle, professor of pedi... read more

Blood cancer sufferers given lifeline after pill approved

Patients who have exhausted other treatment options will now have access ... ‘This is a very important drug, which improves both the control of myeloma and increases how long patients stay alive,’ sai... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us